Ralf Wilkowski
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 27
- Pancreatic and Hepatic Oncology Research 24
-
- Renal cell carcinoma treatment 5
- Co-authors
- Volker Heinemann (25 shared papers)P Stieber (9 shared papers)Stefan Holdenrieder (6 shared papers)Andreas Schalhorn (5 shared papers)Christiane J. Bruns (11 shared papers)Stefan Boeck (8 shared papers)Martin Thoma (6 shared papers)Axel Hinke (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Tumor Biology (3 papers)Clinical Cancer Research (2 papers)Strahlentherapie und Onkologie (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- GermanyNetherlandsItaly
In The Last Decade
Ralf Wilkowski
46 papers receiving 1.8k citations
Ralf Wilkowski's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.1k
- Cancer Research 319
- Pulmonary and Respiratory Medicine 323
- Epidemiology 219
- Hepatology 48
Countries citing papers authored by Ralf Wilkowski
This map shows the geographic impact of Ralf Wilkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Wilkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Wilkowski more than expected).
Fields of papers citing papers by Ralf Wilkowski
This network shows the impact of papers produced by Ralf Wilkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Wilkowski. The network helps show where Ralf Wilkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralf Wilkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer Hit paper breakdown → | 2006 | 535 |
| 2 | 2006 | 139 | |
| 3 | 2008 | 114 | |
| 4 | 2008 | 93 | |
| 5 | 2003 | 57 | |
| 6 | Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. | 2006 | 56 |
| 7 | CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin. | 1999 | 52 |
| 8 | 1996 | 51 | |
| 9 | 2004 | 47 | |
| 10 | 2010 | 45 | |
| 11 | 2007 | 44 | |
| 12 | Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. | 2006 | 43 |
| 13 | 2009 | 42 | |
| 14 | 2007 | 39 | |
| 15 | 2010 | 36 | |
| 16 | 2005 | 36 | |
| 17 | 2003 | 35 | |
| 18 | 2010 | 33 | |
| 19 | 2008 | 33 | |
| 20 | 2010 | 32 |
About Ralf Wilkowski
Ralf Wilkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Surgery, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Cancer Genomics and Diagnostics (8 papers), Neuroendocrine Tumor Research Advances (6 papers), Renal cell carcinoma treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Pancreatitis Pathology and Treatment (3 papers), DNA Repair Mechanisms (2 papers) and Advanced Radiotherapy Techniques (2 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (319 citations), Pulmonary and Respiratory Medicine (323 citations), Epidemiology (219 citations) and Hepatology (48 citations). Ralf Wilkowski has collaborated with scholars based in Germany, Netherlands and Italy. Frequent co-authors include Volker Heinemann, P Stieber, Stefan Holdenrieder, Andreas Schalhorn, Christiane J. Bruns, Stefan Boeck, Martin Thoma, Axel Hinke, A. Rost and Frank Gieseler. Their work appears in journals such as Journal of Clinical Oncology, Tumor Biology, Clinical Cancer Research, Strahlentherapie und Onkologie and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.